Novartis says it benefited from the weakness of the U.S. dollar against other major currencies.
The Basel-based company also saw strong sales of newly launched products such as the oral multiple sclerosis medicine Gilenya.
Novartis earned $2.44 billion during the same period last year on sales of $11.72 billion.
The company said Tuesday that sales in the April to June period increased by 19 percent to reach $14.92 billion.
Related Post:
earnings Report
- Earnings Reports Next Week April 30-May 4 2012
- Starbucks Q2 earning estimates report april 26 2012
- Zacks Analyst AT&T earning estimates released april 24 2012
- AT&T Ahead of Apple Earnings released april 24 2012
- Petrobras forecast 2012
- BMW net profit rose third quarter 2011
- Zipcar will earnings report november 2 2011
- MasterCard financial results third quarter of 2011
- Sony (SNE) earning report per share november 2 2011
- Samsung net profit falls Q3 2011
No comments:
Post a Comment